Wednesday broker round-up UPDATE
3rd Jul 2013 09:16
Aberdeen Asset Management: Bank of America reduces target price from 410p to 360p maintaining an underperform rating. ARM Holdings: UBS upgrades to buy from neutral, keeps target price at 970p. Cineworld: Investec ups target price from 347p to 360p and keeps a buy recommendation. N+1 Singer moves
Read moreCineworld first half revenue jumps 10.5 per cent
3rd Jul 2013 08:21
Cinema chain Cineworld said it expects momentum to continue into the third quarter as it posts a 10.5 per cent increase in first half revenue. The group reported a 10.4% rise in box office revenue during the half year, helped by a 4.6% increase in the average ticket price and a 5.5% rise in admissi
Read moreCineworld and IMAX to add three new theatres across UK
24th Jun 2013 13:36
IMAX and UK cinema chain Cineworld Group have announced the expansion of their revenue sharing agreement with the addition of three IMAX theatre systems to be located in new construction projects including Telford and Broughton, near Chester. The deal will bring Cineworld's total IMAX footprint to
Read moreThursday broker round-up UPDATE
9th May 2013 07:23
Alkane Energy: Liberum Capital initiates with a target price of 44p and a buy recommendation. Anite: Panmure Gordon shifts target price from 170p to 171p and maintains a buy recommendation. Atkins: Credit Suisse raises target price from 770p to 822p, but downgrades to underperform. Avacta Group:
Read moreBroker tips: Antofagasta, Reed Elsevier, Cineworld
1st May 2013 11:20
FIrst-quarter production results from copper miner Antofagasta were well-received by the market on Wednesday but Investec has kept its 'reduce' rating for the stock given a weaker commodity price environment. "The recent drop in commodity prices is leading toward negative provisional price adjustme
Read moreBroker snap: Canaccord upbeat about Cineworld despite OFT referral
1st May 2013 11:17
Canaccord Genuity has kept its 'buy' rating and 360p target price for cinema chain Cineworld saying that the Office of Fair Trading's (OFT) referral of the Picturehouse takeover to the Competition Commission will not affect the business. Analyst Wayne Brown admitted the the OFT referral was of no s
Read moreWednesday newspaper round-up: ENRC, Apple, Chinese manufacturing...
1st May 2013 06:20
According to the Financial Times, the UK Listings Authority has launched an investigation into ENRC possible breaches of its takeover rues that could result in a fine or public censure. "The irony of the move is that the UK Listings Authority has been criticised for permitting ENRC to list in the UK
Read moreThursday broker round-up UPDATE
4th Apr 2013 07:32
Aviva: Bank of America cuts target price from 350p to 335p, while its neutral rating remains unchanged. Barratt Developments: Credit Suisse revises target price from 223p to 317p, while staying with its neutral rating. Bellway: Credit Suisse moves target price from 1202p to 1639p and leaves its ou
Read moreMonday broker round-up UPDATE
25th Mar 2013 07:12
Amur Minerals Corporation: HB Markets initiates with a speculative buy. ARM Holdings: Bank of America Merrill Lynch reiterates buy and 1,145p price target. AstraZeneca: Deutsche Bank raises target price from 2800p to 3100p and keeps a hold recommendation. Exane BNP ups target price from 3100p to 3
Read moreThursday broker round-up UPDATE
7th Mar 2013 07:25
Admiral: Nomura raises target price from 1350p to 1493p keeping a buy recommendation. African Barrick Gold: Nomura cuts target price from 435p to 200p and downgrades from neutral to reduce. Aggreko: Investec increases target price from 1750p to 1940p upgrading from hold to buy. Anglo American: No
Read moreThursday broker round-up UPDATE
17th Jan 2013 07:19
African Barrick Gold: Westhouse Securities reduces target price from 335p to 305p, while its sell recommendation is unchanged. Anglo American: Exane cuts target price from 2000p to 1650p and downgrades from neutral to underperform. Antofagasta: Exane ups target price from 1400p to 1500p keeping an
Read moreWednesday tips round-up: Rexam, Dechra Pharmaceuticals, Cineworld
9th Jan 2013 06:44
Selling on about 11 times 2013 holdings consumer packaging giant Rexam looks a solid long-term investment, given the prospects of further cash returns, the Times's Tempus column wrote last night. That follows the company's announcement on Wednesday that the company is set to return 395m pounds to it
Read moreCineworld poised to meet full year forecasts
8th Jan 2013 08:41
Cinema chain Cineworld said it expects 2012 profit to be in line with forecasts despite distractions from the Diamond Jubilee, Olympics and European Football Championship. As expected, the full year was weighted towards the fourth quarter as moviegoers flocked to see the latest Bond movie Skyfall w
Read moreFormer Guinness Peat Chairman trims his stake...again
19th Dec 2012 16:30
Sir Ron Brierley, a non-executive director of Guinness Peat Group (GPG), sold five million shares in the investment holding company for a second week running. Brierley, a well-known New Zealand investor, offloaded the shares on Wednesday at a price of A$0.47 each (30.31p), pocketing a total of A$2.
Read moreGreene King CEO sells a chunk of share awards
11th Dec 2012 15:57
Rooney Anand, the Chief Executive of pubs group Greene King, pocketed nearly half a million pounds yesterday by selling off a portion of the shares he was awarded under the company's long-term incentive awards (LTIP) a few years back. Under the LTIP awards that were granted to a number of senior ex
Read more